Dietary Supplements

Browse Dietary Supplements Content

“CHPA and its member companies look forward to working with Secretary Kennedy to advance policies that will enhance American consumers’ access to safe, effective, and affordable self-care options. With a growing demand for OTC medicines, dietary supplements, and OTC medical devices, it is imperative that our nation’s healthcare leaders expand access, streamline regulatory pathways, and reinforce public confidence through transparent, data-driven decisions. This can be achieved through the reauthorization of the Over-the-Counter Monograph Drug User Fee Program (OMUFA), Rx-to-OTC switch improvements, and the modernization of the more than 30-year-old Dietary Supplement Health and Education Act (DSHEA).

Feb 12, 2025

The Consumer Healthcare Products Association (CHPA) today announced the recent hiring of Dr. Fred Meadows as its new Senior Director of Quality, Technical, and Regulatory Affairs and Dr. Caitlin Ondracek as its new Senior Director of Medical Science and Regulatory Affairs. Meadows will report to Dr. Marcia Howard, Vice President of Regulatory and Scientific Affairs, and Ondracek will report to Dr. Jay Sirois, Vice President of Regulatory and Scientific Affairs.

Jan 31, 2025

CHPA supports well-tailored efforts to protect the sensitive personal data of U.S. persons, including efforts intended to protect and strengthen the national security of the United States.

Nov 28, 2024

Fearing links to human health problems and harm to the environment, state lawmakers are increasingly seeking to restrict the use and/or presence of PFAS in consumer products and packaging, whether intentionally added or not.

Nov 20, 2024

As more and more consumers turn to dietary supplements to fill nutrition gaps and support general health and wellness, a growing number of state governments are seeking to regulate these products to ensure the health and safety of constituents who may be consuming them. One area of interest to policymakers in recent years is the category of weight loss products.

Nov 20, 2024

OTC medical devices like bandages, menstrual products, face masks, and at-home test kits, used for the purposes of prevention, testing, and treatment are well-accepted, cost saving elements of the healthcare system. Unfortunately, most states that have a retail sales tax, include a tax on the sale of some or all OTC healthcare products. More than 40 states, on the other hand, exempt sales tax of prescription drugs.

Nov 19, 2024

CHPA supports the Agency’s directive to increase enrollment of participants from historically underrepresented populations in clinical trials to improve the strength and generalizability of the evidence to demonstrate safety and/or effectiveness of FDA-regulated medical products, but requests clarification on several points.

Oct 29, 2024

CHPA released the below statement following the passage of A1848 by the New Jersey Assembly today. This legislation seeks to ban the sale of over-the-counter (OTC) weight loss diet pills and dietary supplements marketed for weight loss and muscle building to individuals under 18 years old. While CHPA accepts age restrictions on products explicitly marketed for weight loss, recent amendments to the bill have broadened its scope. The changes now unnecessarily encompass general health supplements containing certain ingredients – including creatine and green tea extract – which are commonly used in many products unrelated to weight loss.

Oct 28, 2024

(WASHINGTON, DC) – The Health In Hand Foundation today released the following statement announcing the 2024 U.S. Self-Care Marketing Awards finalists. Winners for each category will be announced at the 9th annual Health In Hand Foundation Gala on November 13 at The Bellevue Hotel in Philadelphia. Specific awards will recognize the strategic innovation and marketing expertise of CHPA member companies across over-the-counter (OTC) medicine, consumer medical device, and dietary supplement categories.

Sep 9, 2024

Filter Results